- Home
- SVM vs VIR Comparison
SVM vs VIR Comparison
Compare SVM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- VIR
- Stock Information
- Founded
- SVM N/A
- VIR 2016
- Country
- SVM Canada
- VIR United States
- Employees
- SVM N/A
- VIR N/A
- Industry
- SVM Precious Metals
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- VIR Health Care
- Exchange
- SVM Nasdaq
- VIR Nasdaq
- Market Cap
- SVM 663.6M
- VIR 1.0B
- IPO Year
- SVM N/A
- VIR 2019
- Fundamental
- Price
- SVM $3.12
- VIR $7.34
- Analyst Decision
- SVM Strong Buy
- VIR Buy
- Analyst Count
- SVM 1
- VIR 5
- Target Price
- SVM $5.10
- VIR $36.40
- AVG Volume (30 Days)
- SVM 3.1M
- VIR 1.4M
- Earning Date
- SVM 02-06-2025
- VIR 02-20-2025
- Dividend Yield
- SVM 0.85%
- VIR N/A
- EPS Growth
- SVM 63.39
- VIR N/A
- EPS
- SVM 0.29
- VIR N/A
- Revenue
- SVM $241,357,000.00
- VIR $78,618,000.00
- Revenue This Year
- SVM $32.50
- VIR N/A
- Revenue Next Year
- SVM $6.46
- VIR N/A
- P/E Ratio
- SVM $11.73
- VIR N/A
- Revenue Growth
- SVM 16.71
- VIR N/A
- 52 Week Low
- SVM $2.22
- VIR $6.56
- 52 Week High
- SVM $5.32
- VIR $13.09
- Technical
- Relative Strength Index (RSI)
- SVM 44.03
- VIR 46.86
- Support Level
- SVM $2.88
- VIR $7.22
- Resistance Level
- SVM $3.09
- VIR $7.64
- Average True Range (ATR)
- SVM 0.11
- VIR 0.35
- MACD
- SVM 0.04
- VIR 0.00
- Stochastic Oscillator
- SVM 60.39
- VIR 56.52
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.